Retrospective analysis of clinical outcomes and risk factors in hematopoietic cell transplantation for relapsed or refractory mantle cell lymphoma in the post-ibrutinib era.
1/5 보강
OpenAlex 토픽 ·
Lymphoma Diagnosis and Treatment
Chronic Lymphocytic Leukemia Research
Cutaneous lymphoproliferative disorders research
APA
Satoshi Yamasaki, Yutaka Shimazu, et al. (2026). Retrospective analysis of clinical outcomes and risk factors in hematopoietic cell transplantation for relapsed or refractory mantle cell lymphoma in the post-ibrutinib era.. Scientific reports. https://doi.org/10.1038/s41598-026-47347-3
MLA
Satoshi Yamasaki, et al.. "Retrospective analysis of clinical outcomes and risk factors in hematopoietic cell transplantation for relapsed or refractory mantle cell lymphoma in the post-ibrutinib era.." Scientific reports, 2026.
PMID
41936620 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study.
- Male Patients With β-Catenin-Positive Atypical Hepatocellular Neoplasm Arising in Inflammatory Hepatocellular Adenoma: A Case Report.
- Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients.
- Prognostic value of inflammation- and nutrition-based biomarkers in patients with recurrent or metastatic oral squamous cell carcinoma treated with immune checkpoint inhibitors: A retrospective study.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy.
- Fingertip Fissures Associated with Ibrutinib in an Elderly Patient with Mantle Cell Lymphoma.
- Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patients.
- Bruton protein-tyrosine kinase (BTK) FDA-approved small molecule inhibitors used for the management of neoplastic and inflammatory disorders.
- Effect of age and sex on cardiovascular outcomes among patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors: a propensity matched analysis.
- Cost-effectiveness of zanubrutinib versus ibrutinib in the first-line treatment for patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in China.